Teresa Whalen Email

CEO . CytoAgents

Pittsburgh, PA

Location

Current Roles

Employees:
13
Revenue:
$1M
About
CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation. There are many causes of CRS and our mission is to develop a broadly accessible treatment for multiple indications of high unmet need. Using a novel approach by calming the natural immune response to a multi organ disease, CytoAgemts' lead drug candidate, GP1681, is positioned to become a new best practice in medicine.
CytoAgents Address
100 S. Commons
Pittsburgh, PA
CytoAgents Email

Past Companies

CytoAgentsCEO
St. Clair HospitalMember Board Of Directors
Next Act Fund LLCMember, Investment Committee Co-Chair

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.